Literature DB >> 2163835

Studies on the structure and regulation of the human hepatic interleukin-6 receptor.

S Rose-John1, H Schooltink, D Lenz, E Hipp, G Dufhues, H Schmitz, X Schiel, T Hirano, T Kishimoto, P C Heinrich.   

Abstract

Affinity cross-linking of 125I-labeled recombinant human interleukin-6 (IL-6) to human hepatoma cells (HepG2) allowed the detection of three IL-6-containing complexes with molecular masses of 100 kDa, 120 kDa and 200 kDa. Treatment of HepG2 cells with dexamethasone led to a time- and dose-dependent up-regulation of IL-6-receptor mRNA levels. By the use of cross-linking this effect was also seen at the protein level, where all three IL-6-binding complexes increased upon incubation of HepG2 cells with dexamethasone. Under conditions of IL-6-receptor up-regulation by dexamethasone, gamma-fibrinogen mRNA induction by IL-6 is stronger and occurs earlier than without dexamethasone. We propose therefore that the expression of the IL-6 receptor might be a rate-limiting step in acute-phase-protein induction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163835     DOI: 10.1111/j.1432-1033.1990.tb15548.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  22 in total

1.  Mediators of the Jak/STAT signaling pathway in human spermatozoa.

Authors:  Catherine Lachance; Pierre Leclerc
Journal:  Biol Reprod       Date:  2011-08-31       Impact factor: 4.285

2.  Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicity.

Authors:  Sylvia S W Ng; Hong Zhang; Lisa Wang; Deborah Citrin; Laura A Dawson
Journal:  NPJ Precis Oncol       Date:  2020-07-14

3.  Stimulation of CRP secretion in HepG2 cells: cooperative effect of dexamethasone and interleukin 6.

Authors:  S Depraetere; J Willems; M Joniau
Journal:  Agents Actions       Date:  1991-11

Review 4.  IL-6 biology: implications for clinical targeting in rheumatic disease.

Authors:  Leonard H Calabrese; Stefan Rose-John
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

5.  Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes.

Authors:  J E Nesbitt; G M Fuller
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

6.  Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).

Authors:  Christoph Garbers; Fabian Kuck; Samadhi Aparicio-Siegmund; Kirstin Konzak; Mareike Kessenbrock; Annika Sommerfeld; Dieter Häussinger; Philipp A Lang; Dirk Brenner; Tak W Mak; Stefan Rose-John; Frank Essmann; Klaus Schulze-Osthoff; Roland P Piekorz; Jürgen Scheller
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

7.  The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines.

Authors:  M Hiron; M Daveau; P Arnaud; J Bauer; J P Lebreton
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

Review 8.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

9.  Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells.

Authors:  H Schooltink; T Stoyan; D Lenz; H Schmitz; T Hirano; T Kishimoto; P C Heinrich; S Rose-John
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

10.  Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Authors:  David A Jackson; Timothy D Smith; Nansalmaa Amarsaikhan; Weiguo Han; Matthew S Neil; Shannon K Boi; Anne M Vrabel; Ezequiel J Tolosa; Luciana L Almada; Martin E Fernandez-Zapico; Sherine F Elsawa
Journal:  J Immunol       Date:  2015-08-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.